Be Sure To Check Out Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Before It Goes Ex-Dividend
NiveshIQ
NSE: CAPLIPOINT · Healthcare
Caplin Point Laboratories Ltd.
₹2,754.90▼ ₹40.50 (-1.45%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on CAPLIPOINT. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Caplin Point Laboratories Ltd.
Caplin Point Laboratories Limited is a leading Indian pharmaceutical company that develops, produces, and markets generic formulations and branded products. The company's core business is driven by its diverse product portfolio, which includes tablets, capsules, injections, and other pharmaceutical products. With a strong presence in the Indian market, Caplin Point Laboratories has been expanding its reach into key markets, resulting in double-digit revenue and profit growth in Q1 FY27. The company's revenue grew 20.7% YoY to ₹644 Crores, with PAT up 18.8% to ₹179 Crores. Caplin Point Laboratories has a competitive position in the Indian pharmaceutical market, with a strong brand portfolio and a wide range of products. The company's growth outlook is positive, driven by its expanding produ
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,694 Cr +15.50% | ₹1,937 Cr +14.30% | ₹2,187 Cr |
| EBITDA Margin | 32.53% | 33.40% | 0.00% |
| Net Profit | ₹461.00 Cr +22.30% | ₹541.00 Cr +17.40% | ₹650.00 Cr |
| EPS | ₹60.19 | ₹70.56 | ₹84.36 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Be Sure To Check Out Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Before It Goes Ex-Dividend
Caplin Point Share Price Today, Caplin Point Stock Price Live NSE/BSE Updates
🔒
+ 3 more stories about Caplin Point Laboratories Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹600 Cr, PAT ₹173 Cr, EPS ₹22.38. Growth context: revenue QoQ +10.5%, PAT QoQ +4.2%. Street verdict: beat, revenue surprise +10.9%, PAT surprise +19.5%.
Management commentary points to new capacity addition and capex deployment as the primary near-term growth lever, with e...
FY26 (last completed FY): revenue ₹2, 187 Cr, PAT ₹650 Cr, EPS ₹84.36. Street consensus for FY27e: revenue ₹2, 488 Cr, P...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for CAPLIPOINT
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track CAPLIPOINT alongside your other holdings
Unlock full CAPLIPOINT research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Caplin Point Laboratories Ltd.?
NiveshIQ detects active intelligence signals for Caplin Point Laboratories Ltd. (CAPLIPOINT) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Caplin Point Laboratories Ltd.?
Caplin Point Laboratories Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,410,777.1L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.